Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Innovative DNA technology speeds up TB diagnosis
DNA
Whole Genome Sequencing is a faster, cheaper and more effective way of diagnosing TB.

Whole Genome Sequencing found to be more effective

Scientists are using innovative DNA technology to diagnose cases of TB up to eight times faster than traditional methods.

A study led by the University of Oxford concludes that Whole Genome Sequencing is a faster, cheaper and more effective way of diagnosing TB.

The researchers say that the method marks 'a significant milestone' in the way TB is tackled, but the outlook looks even better, as whole genome sequencing technology is set to improve.

Whole Genome Sequencing has been used before in TB research studies, but this is the first time that it has been applied in real world scenarios.

In the study, the researchers were able to detect presence of TB and whether it was resistant to commonly used antibiotics within one week - up to eight times faster than utilising traditional diagnosis methods. 

Furthermore, the fast diagnosis meant the scientists were able to detect and respond to potential outbreaks as they happen.

The method has also proven to be more cost-effective, at an average of £481 per positive case, compared to £517 per case using current technologies.

Lead author Dr Louise Pankhurst from the University of Oxford, said: "This is a really exciting time to be working in infectious disease research. The UK is poised to become the first country in the world to replace traditional tuberculosis diagnosis with whole genome sequencing.

"Our study has shown how this will dramatically speed up the time taken to diagnose TB, helping patients be placed on the most effective treatment as soon as possible and reducing the risk of disease transmission."

The research, Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study is published in the Lancet Respiratory Medicine.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.